PE20070139A1 - DERIVADOS DE PIRIDO[2,3-d]PIRIMIDINA Y SU PREPARACION - Google Patents
DERIVADOS DE PIRIDO[2,3-d]PIRIMIDINA Y SU PREPARACIONInfo
- Publication number
- PE20070139A1 PE20070139A1 PE2006000754A PE2006000754A PE20070139A1 PE 20070139 A1 PE20070139 A1 PE 20070139A1 PE 2006000754 A PE2006000754 A PE 2006000754A PE 2006000754 A PE2006000754 A PE 2006000754A PE 20070139 A1 PE20070139 A1 PE 20070139A1
- Authority
- PE
- Peru
- Prior art keywords
- dimethylethyl
- pyrimidin
- urea
- alkyl
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UN COMPUESTO DERIVADO DE PIRIDO[2,3-d]PIRIMIDINA DE FORMULA (I) DONDE R1 ES ALQUILO (C1-C6), ALQUIL(C1-C6)-CICLOALQUILO(C3-C7), CH2COR3, FENILO, ENTRE OTROS, DONDE R3 ES OH, ALCOXI(C1-C4), NH, ALQUILAMINO(C1-C4), ENTRE OTROS; Ar1 ES UN RADICAL DE FORMULA (e), (f), ENTRE OTROS; Ar2 ES FENILO OPCIONALMENTE SUSTITUIDO CON HALOGENO, ALQUILO(C1-C4), TRIFLUOROMETILO O ALCOXI(C1-C4). SON COMPUESTOS PREFERIDOS: N-[2-(2,1,3-BENZOTIADIAZOL-4-ILAMINO)-6-(2,6-DICLOROFENIL)PIRIDO[2,3-d]PIRIMIDIN-7-IL]-N'-(1,1-DIMETILETIL)-UREA, N-[6-(2,6-DICLOROFENIL)-2-[(1,3-DIHIDRO-2,2-DIOXIDO-2,1-BENZISOTIAZOL-5-IL)AMINO]PIRIDO[2,3-d]PIRIMIDIN-7-IL]-N'-(1,1-DIMETILETIL)-UREA, N-[6-(2,6-DICLOROFENIL)-2-[(2-METIL-6-BENZOXAZOLIL)AMINO]PIRIDO[2,3-d]PIRIMIDIN-7-IL]-N'-(1,1-DIMETILETIL)-UREA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA PROLIFERACION DE CELULAS TUMORALES SIENDO UTILES EN EL TRATAMIENTO DE LEUCEMIAS, CANCER DE MAMA, CANCER DE PULMON, ARTERIOESCLEROSIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0507032A FR2887882B1 (fr) | 2005-07-01 | 2005-07-01 | Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070139A1 true PE20070139A1 (es) | 2007-03-07 |
Family
ID=36096420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000754A PE20070139A1 (es) | 2005-07-01 | 2006-06-28 | DERIVADOS DE PIRIDO[2,3-d]PIRIMIDINA Y SU PREPARACION |
Country Status (41)
Country | Link |
---|---|
US (2) | US7504406B2 (es) |
EP (2) | EP2020410B1 (es) |
JP (1) | JP4472009B2 (es) |
KR (1) | KR101298344B1 (es) |
CN (2) | CN102260258B (es) |
AR (1) | AR054812A1 (es) |
AT (1) | ATE423119T1 (es) |
AU (1) | AU2006264801B2 (es) |
BR (1) | BRPI0613020A2 (es) |
CA (1) | CA2610794C (es) |
CR (1) | CR9568A (es) |
CY (2) | CY1110457T1 (es) |
DE (1) | DE602006005246D1 (es) |
DK (2) | DK1902054T3 (es) |
DO (1) | DOP2006000145A (es) |
EA (1) | EA014312B1 (es) |
EC (1) | ECSP078011A (es) |
ES (2) | ES2450067T3 (es) |
FR (1) | FR2887882B1 (es) |
HK (1) | HK1122797A1 (es) |
HR (2) | HRP20090236T1 (es) |
IL (1) | IL187900A0 (es) |
JO (1) | JO2550B1 (es) |
MA (1) | MA29561B1 (es) |
ME (1) | ME01813B (es) |
MX (1) | MX2007016239A (es) |
MY (1) | MY143089A (es) |
NO (1) | NO20080418L (es) |
NZ (1) | NZ564072A (es) |
PA (1) | PA8684801A1 (es) |
PE (1) | PE20070139A1 (es) |
PL (2) | PL1902054T3 (es) |
PT (2) | PT2020410E (es) |
RS (2) | RS50781B (es) |
SI (2) | SI2020410T1 (es) |
TN (1) | TNSN07440A1 (es) |
TW (1) | TWI321566B (es) |
UA (1) | UA92021C2 (es) |
UY (1) | UY29645A1 (es) |
WO (1) | WO2007003765A1 (es) |
ZA (1) | ZA200711032B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2873118B1 (fr) | 2004-07-15 | 2007-11-23 | Sanofi Synthelabo | Derives de pyrido-pyrimidine, leur application en therapeutique |
FR2887882B1 (fr) * | 2005-07-01 | 2007-09-07 | Sanofi Aventis Sa | Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique |
FR2896246B1 (fr) | 2006-01-13 | 2008-08-15 | Sanofi Aventis Sa | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. |
FR2910813B1 (fr) * | 2006-12-28 | 2009-02-06 | Sanofi Aventis Sa | Nouvelle utilisation therapeutique pour le traitement des leucemies |
AU2009304596A1 (en) | 2008-10-17 | 2010-04-22 | Akaal Pharma Pty Ltd | S1P receptors modulators |
AU2009304598B2 (en) * | 2008-10-17 | 2015-01-29 | Akaal Pharma Pty Ltd | S1P receptors modulators and their use thereof |
FR2948568B1 (fr) * | 2009-07-30 | 2012-08-24 | Sanofi Aventis | Formulation pharmaceutique |
CN103204822B (zh) | 2012-01-17 | 2014-12-03 | 上海科州药物研发有限公司 | 作为蛋白激酶抑制剂的苯并噁唑化合物及其制备方法和用途 |
EP2638911A1 (en) | 2012-03-14 | 2013-09-18 | Sanofi | Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemia |
CN103833771A (zh) * | 2012-11-22 | 2014-06-04 | 天津滨江药物研发有限公司 | 作为蛋白激酶Mek抑制剂的苯并五元杂环化合物及其制备方法和用途 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1171218A (en) * | 1967-11-09 | 1969-11-19 | Parke Davis & Co | New Heterocyclic Amine Compounds and Methods for their Production |
JPH04128276A (ja) | 1990-09-19 | 1992-04-28 | Pfizer Pharmaceut Co Ltd | アミノベンゾサルタム誘導体およびその用途 |
GEP20012444B (en) * | 1994-11-14 | 2001-05-25 | Warner Lambert Company Us | 6-Aryl Pyrido[2,3-d]Pyrimidines and Naphthyridines, Pharmaceutical Composition on Their Basis and Application for Inhibiting Cellular Proliferation |
IL115256A0 (en) | 1994-11-14 | 1995-12-31 | Warner Lambert Co | 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use |
US5620981A (en) * | 1995-05-03 | 1997-04-15 | Warner-Lambert Company | Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation |
IL117923A (en) | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
AR030044A1 (es) * | 2000-01-25 | 2003-08-13 | Warner Lambert Co | Pirido (2,3-d ) pirimidin-2,7-diaminas inhibidores de quinasas |
OA12227A (en) * | 2000-03-06 | 2004-03-18 | Warner Lambert Co | 5-AlkylpyridoÄ2,3-DÜpyrimidines tyrosine kinase inhibitors. |
DE60135854D1 (de) | 2000-08-04 | 2008-10-30 | Warner Lambert Co | 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-one |
AU2002324450A1 (en) * | 2001-06-21 | 2003-01-08 | Ariad Pharmaceuticals, Inc. | Novel pyridopyrimidines and uses thereof |
AU2002952453A0 (en) * | 2002-11-01 | 2002-11-21 | Novogen Research Pty Ltd | Aminated isoflavonoid derivatives and uses thereof |
WO2004063195A1 (en) | 2003-01-03 | 2004-07-29 | Sloan-Kettering Institute For Cancer Research | Pyridopyrimidine kinase inhibitors |
TW200502236A (en) * | 2003-03-28 | 2005-01-16 | Hoffmann La Roche | Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
WO2005105097A2 (en) | 2004-04-28 | 2005-11-10 | Gpc Biotech Ag | Pyridopyrimidines for treating inflammatory and other diseases |
FR2873118B1 (fr) | 2004-07-15 | 2007-11-23 | Sanofi Synthelabo | Derives de pyrido-pyrimidine, leur application en therapeutique |
FR2887882B1 (fr) * | 2005-07-01 | 2007-09-07 | Sanofi Aventis Sa | Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique |
FR2896246B1 (fr) | 2006-01-13 | 2008-08-15 | Sanofi Aventis Sa | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. |
US8338435B2 (en) * | 2006-07-20 | 2012-12-25 | Gilead Sciences, Inc. | Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections |
-
2005
- 2005-07-01 FR FR0507032A patent/FR2887882B1/fr not_active Expired - Fee Related
-
2006
- 2006-06-26 DO DO2006000145A patent/DOP2006000145A/es unknown
- 2006-06-28 JO JO2006197A patent/JO2550B1/en active
- 2006-06-28 PE PE2006000754A patent/PE20070139A1/es not_active Application Discontinuation
- 2006-06-29 BR BRPI0613020-8A patent/BRPI0613020A2/pt not_active IP Right Cessation
- 2006-06-29 DE DE602006005246T patent/DE602006005246D1/de active Active
- 2006-06-29 PT PT80179443T patent/PT2020410E/pt unknown
- 2006-06-29 NZ NZ564072A patent/NZ564072A/en not_active IP Right Cessation
- 2006-06-29 EP EP08017944.3A patent/EP2020410B1/fr active Active
- 2006-06-29 AT AT06778710T patent/ATE423119T1/de active
- 2006-06-29 WO PCT/FR2006/001518 patent/WO2007003765A1/fr active Application Filing
- 2006-06-29 ZA ZA200711032A patent/ZA200711032B/xx unknown
- 2006-06-29 ES ES08017944.3T patent/ES2450067T3/es active Active
- 2006-06-29 JP JP2008518918A patent/JP4472009B2/ja not_active Expired - Fee Related
- 2006-06-29 RS RSP-2009/0225A patent/RS50781B/sr unknown
- 2006-06-29 PL PL06778710T patent/PL1902054T3/pl unknown
- 2006-06-29 MX MX2007016239A patent/MX2007016239A/es active IP Right Grant
- 2006-06-29 CN CN201110187994.9A patent/CN102260258B/zh not_active Expired - Fee Related
- 2006-06-29 DK DK06778710T patent/DK1902054T3/da active
- 2006-06-29 PL PL08017944T patent/PL2020410T3/pl unknown
- 2006-06-29 SI SI200631750T patent/SI2020410T1/sl unknown
- 2006-06-29 CN CN2006800237082A patent/CN101213196B/zh not_active Expired - Fee Related
- 2006-06-29 UA UAA200801216A patent/UA92021C2/ru unknown
- 2006-06-29 CA CA2610794A patent/CA2610794C/fr not_active Expired - Fee Related
- 2006-06-29 MY MYPI20063117A patent/MY143089A/en unknown
- 2006-06-29 ES ES06778710T patent/ES2322101T3/es active Active
- 2006-06-29 ME MEP-2014-28A patent/ME01813B/me unknown
- 2006-06-29 EP EP06778710A patent/EP1902054B1/fr active Active
- 2006-06-29 SI SI200630273T patent/SI1902054T1/sl unknown
- 2006-06-29 AU AU2006264801A patent/AU2006264801B2/en not_active Ceased
- 2006-06-29 KR KR1020077030704A patent/KR101298344B1/ko not_active IP Right Cessation
- 2006-06-29 RS RS20140121A patent/RS53211B/en unknown
- 2006-06-29 EA EA200800223A patent/EA014312B1/ru not_active IP Right Cessation
- 2006-06-29 PT PT06778710T patent/PT1902054E/pt unknown
- 2006-06-29 DK DK08017944.3T patent/DK2020410T3/en active
- 2006-06-30 UY UY29645A patent/UY29645A1/es unknown
- 2006-06-30 PA PA20068684801A patent/PA8684801A1/es unknown
- 2006-06-30 AR ARP060102833A patent/AR054812A1/es active IP Right Grant
- 2006-06-30 TW TW095123940A patent/TWI321566B/zh not_active IP Right Cessation
-
2007
- 2007-11-26 TN TNP2007000440A patent/TNSN07440A1/en unknown
- 2007-12-04 IL IL187900A patent/IL187900A0/en not_active IP Right Cessation
- 2007-12-06 CR CR9568A patent/CR9568A/es unknown
- 2007-12-13 EC EC2007008011A patent/ECSP078011A/es unknown
- 2007-12-13 US US11/955,583 patent/US7504406B2/en active Active
- 2007-12-24 MA MA30502A patent/MA29561B1/fr unknown
-
2008
- 2008-01-22 NO NO20080418A patent/NO20080418L/no not_active Application Discontinuation
- 2008-12-18 HK HK08113767.6A patent/HK1122797A1/xx not_active IP Right Cessation
-
2009
- 2009-01-30 US US12/362,656 patent/US8008310B2/en active Active
- 2009-04-22 HR HR20090236T patent/HRP20090236T1/xx unknown
- 2009-05-11 CY CY20091100498T patent/CY1110457T1/el unknown
-
2014
- 2014-03-18 CY CY20141100211T patent/CY1114989T1/el unknown
- 2014-03-18 HR HRP20140246TT patent/HRP20140246T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20070139A1 (es) | DERIVADOS DE PIRIDO[2,3-d]PIRIMIDINA Y SU PREPARACION | |
PE20060504A1 (es) | Derivados de pirimidina en el tratamiento de cancer | |
EA200501866A1 (ru) | Макроциклические производные хиназолина в качестве антипролиферативных средств | |
PE20061305A1 (es) | Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas | |
PE20141351A1 (es) | Triazolopiridinas | |
BE2017C018I2 (es) | ||
PE20130611A1 (es) | Triazolopiridinas sustituidas | |
CY1118498T1 (el) | Παραγωγα πυριδαζινονης | |
MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
PE20061067A1 (es) | Derivados de pirimidina | |
PE20110560A1 (es) | NUEVOS DERIVADOS DE TRIAZOLO[4,3-a]PIRIDINA, SU PROCEDIMIENTO DE PREPARACION, SU APLICACION COMO MEDICAMENTOS, COMPOSICIONES FARMACEUTICAS Y NUEVA UTILIZACION PARTICULARMENTE COMO INHIBIDORES DE MET | |
GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
EA200701853A1 (ru) | Производные циклопентапиридина и тетрагидрохинолина | |
IL191832A (en) | Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors | |
GEP20156282B (en) | Compounds and compositions as protein kinase inhibitors | |
NO20054185L (no) | Methods of radiofluorination of biologically active vectors | |
MXPA05013349A (es) | Derivados de 2-amino-pirimidina como inhibidores de quinasa raf. | |
EA201100971A1 (ru) | Производные пиримидининдола для лечения злокачественного новообразования | |
MY148375A (en) | Delta and epsilon crystal forms of imatinib mesylate | |
TW200614987A (en) | Novel compounds | |
PE20061110A1 (es) | Derivados de imidazopiridina como antagonistas de la bomba de acido (apa) | |
PE20091101A1 (es) | AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO | |
PE20110584A1 (es) | DERIVADOS DE IMIDAZO[1,2-a]PIRIMIDINA COMO INHIBIDORES DE MET, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU PROCEDIMIENTO DE PREPARACION | |
WO2007125398A3 (en) | : sulfonamide compounds as antagonists of the n-type calcium channel | |
GEP20074058B (en) | 4-(7-halo-2-quino(xa) linyloxy-phenoxy-propionic acid derivatives as antineoplastic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |